Use of a combination of a forebrain selective N-methyl-D-aspartate antagonist and excitatory feedback enhancing agent in the preparation of pharmaceutical composition for treating Parkinson's disease

摘要

This invention relates to a method of treating Parkinson's Disease whereby a mammal suffering from Parkinson's Disease is treated with a combination of a forebrain selective NMDA antagonist and a compound which is capable of increasing the excitatory feedback from the ventral lateral nucleus of the thalamus into the cortex. This invention also relates to pharmaceutical compositions containing the synergistic combination.